CClinicalTrials.gg
CompletedNCT04974762Updated Aug 4, 2022

Truncal Blocks Versus Wound Infiltration for SICD

An interventional study of Wound infiltration and Truncal blocks in Intraoperative Pain and Postoperative Pain, sponsored by Icahn School of Medicine at Mount Sinai. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-08-04.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Jan 2019, registered Jul 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks. Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay.

Read the detailed description

This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks. Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay. The procedures involved for the study are the placement of the described truncal blocks or wound infiltration. Data to be collected are patient demographics, history of present illness, past medical history, and pain management techniques required (i.e non-narcotics and narcotics use). In addition, age, race, gender and BMI will also be collected. Intraoperative analgesia requirements, postoperative analgesia requirements, duration of procedure and length of stay will also be collected.

02

Conditions studied

  • Intraoperative Pain
  • Postoperative Pain

Browse trials for

Keywords

  • Subcutaneous implantable cardioverter-defibrillators (S-ICD)
  • Truncal blocks
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 24 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Icahn School of Medicine at Mount Sinai is the lead sponsor of 764 studies on the registry; 181 are open to participants now.

Of its 121 completed or terminated interventional studies of FDA-regulated products, 82 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients over 18 years of age
  • Patients undergoing S-ICD placement

Exclusion criteria

Exclusion Criteria:

  • Allergy to amide local anesthetics
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Active comparator
    Wound infiltration

    Standard intervention - surgical infiltration with local anesthetics

    Procedure: Wound infiltration

  • Experimental
    Truncal blocks

    Truncal block for anesthetics

    Procedure: Truncal blocks

Interventions

  • ProcedureWound infiltration

    Surgical wound infiltration by proceduralist

  • ProcedureTruncal blocks

    Truncal blocks provided by anesthesiology team for device placement

06

What researchers measure

Primary outcomes

  1. Intraoperative and postoperative opioid consumption

    Total intraoperative and postoperative opioid consumption of subjects

    Time frame: Up to Post-Op Day 10

Secondary outcomes

  1. Non-opioid analgesic consumption

    Total intraoperative and postoperative non-opioid analgesic consumption of subjects

    Time frame: Up to Post-Op Day 10

  2. Sedation (propofol) requirements intraoperatively

    Total propofol required by subjects intraoperatively

    Time frame: Day 1, Day of Surgery

  3. Number of participants with ICU stay

    Need of intensive care unit (ICU) stay

    Time frame: Up to Post-Op Day 10

  4. Duration of ICU stay

    Duration of intensive care unit (ICU) stay

    Time frame: Up to Post-Op Day 10

  5. Visual Analog Pain score

    Visual Analog Pain Score (VAS) - total scale from 0-10, with higher score indicating more pain

    Time frame: Up to Post-Op Day 10

  6. Total procedure time

    Total duration of procedure time measured in minutes

    Time frame: Day 1 at Surgery

  7. Length of stay

    Length of time in the postanesthesia care unit measured in minutes

    Time frame: Day 1 at Surgery

07

Study locations

1 site
  • Mount Sinai Morningside Hospital Center
    New York, New York 10025, United States
08

References and documents

Individual participant data

Plan to share: No — Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices).

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04974762
Lead sponsor
Icahn School of Medicine at Mount Sinai
Responsible party
Ali Nima Shariat (Assistant Professor, Anesthesiology, Perioperative & Pain Medicine, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Jul 23, 2021
Start date
Jan 23, 2019
Primary completion
Feb 18, 2022
Completion
Feb 18, 2022
Last update
Aug 4, 2022

Study contacts

Ali Shariat, MD
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion